Peptide

CJC-1295 with DAC
Function:Hormones and Regulation of Endocrine Function of Drug
Certification:GMP, Reach, SGS, FDA
Grade Standard:Medicine Grade
Type:Chemical Reagent
State:Solid
Volatile:Not Volatile
Name:2mg Vials Cjc 1295 with Dac
Specification:2mgvial, 10vialKit
CAS:863288-34-0
Purity (HPLC):99.3%
Appearance:White Powder
MW:3367.97
Mf.:C159h258n46o45
Store at:Cool Dry Place
Export Markets:Global
Usage: An obstetric drug used to control postpartum hemorrhaging.
CJC-1295 DAC has shown some amazing results as a releasing hormone (GHRH) analog. Not only has CJC-1295 shown the ability to increase and IGF-I secretion and its benefits, but it has been able to do so in very large amounts.
CJC-1295 DAC and CJC-1295 (also known as Modified GRF 1-29) are both Releasing Hormones (GHRH). Their action in the human body is identical but the difference between the two peptides are the span of the half-life.
Modified GRF 1-29 and Sermorelin have a very short acting half-life of about 30 minutes, while CJC-1295 DAC has a half-life that can last up to approximately 8 days.
Many a scientist have reported that the short half-life of Sermorelin and Modified GRF 1-29 is considered to be much more natural as they produce a short pulse of Human .
Application:
CJC-1295 is an injectable peptide used to increase GH production. This peptide is a hormone releasing hormone (GHRH) mimetic, or analog. That is to say, it works in the same way as GHRH, and may be referred to as being a GHRH.
The principal use of CJC-1295 is to provide increased GH levels, which also results in increased IGF-1 levels. An increase in these levels can aid fat loss and in some instances can aid muscle gain as well.
Generally, a product in the GHRH category, including CJC-1295, is chosen as an alternate to using GH, and only rarely is combined with GH.?